share_log

Nuvalent's NVL-655 Receives FDA Breakthrough Therapy Designation

Benzinga ·  May 17 04:02
Nuvalent's NVL-655 Receives FDA Breakthrough Therapy Designation
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment